financetom
Business
financetom
/
Business
/
Exclusive-China's Fosun explores sale of Atlantis Sanya luxury resort, sources say
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exclusive-China's Fosun explores sale of Atlantis Sanya luxury resort, sources say
Mar 4, 2024 10:42 PM

HONG KONG (Reuters) - Fosun International ( FOSUF ) is looking to sell all or part of its luxury resort Atlantis in southern China as part of its efforts to reduce debt, three people with knowledge of the matter said.

Located on Hainan island, known as China's Hawaii, in the seaside city of Sanya, the integrated resort spans an area equivalent to 66 soccer pitches. It boasts a hotel with more than 1,300 guest rooms - some with views of underwater marine life - as well as a water park, an aquarium and a shopping mall.

Fosun ( FOSUF ), known for once being one of China's most acquisition-hungry conglomerates, has sent information to prospective buyers and advisers and has been in informal discussions with them in recent months, said two of the people.

A potential deal value for Atlantis Sanya could not be immediately learned. Fosun ( FOSUF ) said in 2018 it had invested 11 billion yuan ($1.5 billion) in the resort.

The sources declined to be identified as the discussions were confidential. Fosun ( FOSUF ) and its Hong Kong-listed unit Fosun Tourism Group ( FSNGF ), which owns the resort, did not immediately respond to requests for comment.

A sale would be further evidence that the conglomerate, which had some $30 billion in debt as of last June, is willing to roll back its presence in the tourism sector. Fosun Tourism's ( FSNGF ) other main asset is Club Med and sources have said that the conglomerate is exploring the sale of a minority stake in the luxury resort chain.

According to two of the sources, Fosun ( FOSUF ) has targeted mainly Chinese state-backed firms and deep-pocketed investors from the Middle East as potential buyers.

It is open to selling the whole business or the luxury hotel alone, said one of them.

Fosun Tourism ( FSNGF ), which has a market cap of about HK$5.2 billion ($665 million), accounts for 9% of Fosun International's ( FOSUF ) overall revenue. The conglomerate's other businesses span healthcare, financial services and property.

($1 = 7.1993 Chinese yuan)

($1 = 7.8252 Hong Kong dollars)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Dr. Reddy's Laboratories Recalls Batch of Levetiracetam in 0.75% Sodium Chloride Injection in US
Dr. Reddy's Laboratories Recalls Batch of Levetiracetam in 0.75% Sodium Chloride Injection in US
Mar 13, 2025
11:12 AM EDT, 03/13/2025 (MT Newswires) -- Dr. Reddy's Laboratories (RDY) said Thursday it is recalling one batch of levetiracetam in 0.75% sodium chloride injection, 1,000 mg/100 mL single-dose infusion bags across the US. The company said it is recalling the product due to the incorrect labeling of the infusion bag which reads as levetiracetam in 0.82% sodium chloride injection...
SentinelOne Exceeds Q4 Revenue Expectations, But Guidance Concerns Linger, Oppenheimer Says
SentinelOne Exceeds Q4 Revenue Expectations, But Guidance Concerns Linger, Oppenheimer Says
Mar 13, 2025
11:14 AM EDT, 03/13/2025 (MT Newswires) -- SentinelOne's ( S ) fiscal Q4 revenue exceeded expectations and despite posting strong results near-term investor concerns persist due to lower-than-anticipated guidance for the next fiscal year, Oppenheimer said in a note on Thursday. The company demonstrated strong enterprise adoptions with 1,411 customers generating over $100,000 in annual recurring revenue with 40% of...
Kane Biotech Secures Approval to Launch Acne Treatment Trial
Kane Biotech Secures Approval to Launch Acne Treatment Trial
Mar 13, 2025
11:14 AM EDT, 03/13/2025 (MT Newswires) -- Kane Biotech ( KNBIF ) on Thursday said it received approval from the Internal Review Board (IRB) of the University of Miami Health System to launch a clinical study of Kane's prototype DispersinB acne cleanser for the treatment of mild to moderate cases of acne vulgaris. The trial, which is expected to start...
Adobe Investors Need 'Clearer Roadmap' to Dispel 'Apathy' on Shares, Morgan Stanley Says
Adobe Investors Need 'Clearer Roadmap' to Dispel 'Apathy' on Shares, Morgan Stanley Says
Mar 13, 2025
11:10 AM EDT, 03/13/2025 (MT Newswires) -- Adobe (ADBE) investors need a clearer roadmap to dispel apathy surrounding the stock even after the software company's Q1 results topped estimates by analysts, Morgan Stanley said Thursday in a report. Investors look for greater visibility on three key focal points to gain confidence in the forward trajectory of the company, including detailed...
Copyright 2023-2026 - www.financetom.com All Rights Reserved